Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Journal of Agricultural and Food Chemistry|June 3, 2025
Isoxazoline: A Privileged Scaffold for Agrochemical DiscoveryLi Xiong, Rui Zhang, Kai-Long Zhang, et al.Bioorganic & Medicinal Chemistry|July 17, 2019
Optimization and biological evaluation of nicotinamide derivatives as Aurora kinase inhibitorsBaohui Qi, Xingwei Xu, Ying Yang, et al.Bioorganic Chemistry|December 4, 2020
Discovery of 4-((4-(4-(3-(2-(2,6-difluorophenyl)-4-oxothiazolidin-3-yl)ureido)-2-fluorophenoxy)-6-methoxyquinolin-7-yl)oxy)-N,N-diethylpiperidine-1-carboxamide as kinase inhibitor for the treatment of colorectal cancerYuting Zhou, Xingwei Xu, Fei Wang, et al.Bioorganic & Medicinal Chemistry|April 29, 2026
Exploration of a novel series of isoindolinone-based hydroxamate derivatives: Design, synthesis, and evaluation of anticancer activityXizheng Quan, Yumei Chen, Fangli Ma, et al.European Journal of Medicinal Chemistry|December 24, 2023
Identification of novel aminopyrimidine derivatives for the treatment of mutant NSCLCLiping Hu, Shengmin Shi, Xiaomeng Song, et al.Bioorganic & Medicinal Chemistry|November 12, 2023
Design, synthesis and biological evaluation of EGFR kinase inhibitors that spans the orthosteric and allosteric sitesMengmeng Fan, Liping Hu, Shengmin Shi, et al.Archiv Der Pharmazie|July 12, 2013
Synthesis and biological evaluation of 4-phenoxy-6,7-disubstituted quinolines possessing semicarbazone scaffolds as selective c-Met inhibitorsBaohui Qi, Haiyan Tao, Di Wu, et al.European Journal of Medicinal Chemistry|July 31, 2020
Identification of novel quinoline analogues bearing thiazolidinones as potent kinase inhibitors for the treatment of colorectal cancerYuting Zhou, Xingwei Xu, Fei Wang, et al.European Journal of Medicinal Chemistry|June 26, 2012
Synthesis and biological evaluation of novel 2-(2-arylmethylene)hydrazinyl-4-aminoquinazoline derivatives as potent antitumor agentsNan Jiang, Xin Zhai, Yanfang Zhao, et al.European Journal of Medicinal Chemistry|November 8, 2021
Dual target inhibitors based on EGFR: Promising anticancer agents for the treatment of cancers (2017-)Liping Hu, Mengmeng Fan, Shengmin Shi, et al.Pageof 3